SCHEMBL3684765

SCHEMBL3684765

CC(C)(C)N(Cc1cccc(-c2nc(-c3cccnc3)no2)c1)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 7/20 0.54
S1PR1 P21453 3/20 0.51
CHRNB2 P17787 4/20 0.50
CHRNA5 P30532 4/20 0.50
CHRNA4 P43681 4/20 0.50
CA9 Q16790 1/20 0.50
NPC1 O15118 6/20 0.49
RAB9A P51151 6/20 0.49
SMN1; SMN2 Q16637 6/20 0.49
MAPT P10636 6/20 0.49
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 1/20 0.49
HPGD P15428 1/20 0.49
HSD17B10 Q99714 1/20 0.49
LMNA P02545 1/20 0.48
KMT2A Q03164 1/20 0.48
PKM P14618 1/20 0.48
NFKB1 P19838 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1423258 0.81 CHRNB2 (0.61) TP53S1PR1CHRNB2CHRNA5CHRNA4
SCHEMBL10316671 0.78 ALDH1A1 (0.57) TP53S1PR1CHRNB2CHRNA5CHRNA4
SCHEMBL27767567 0.76 S1PR1 (0.52) TP53S1PR1CHRNB2CHRNA5CHRNA4
SCHEMBL1423075 0.76 S1PR1 (0.52) TP53S1PR1CHRNB2CHRNA5CHRNA4
SCHEMBL3715047 0.76 CHRNB2 (0.62) TP53S1PR1CHRNB2CHRNA5CHRNA4
SCHEMBL1422372 0.75 KMO (0.67) TP53S1PR1CHRNB2CHRNA5CHRNA4
SCHEMBL2273541 0.75 CHRNB2 (0.66) TP53S1PR1CHRNB2CHRNA5CHRNA4
Hydrochloric Acid SCHEMBL2278057 0.74 CHRNB2 (0.64) TP53S1PR1CHRNB2CHRNA5CHRNA4
SCHEMBL1422479 0.74 CHRNB2 (0.64) TP53S1PR1CHRNB2CHRNA5CHRNA4
SCHEMBL28784577 0.74 S1PR1 (0.62) TP53S1PR1CHRNB2CHRNA5CHRNA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2226074-A2 Pharmaceutical compositions and their methods of use Abbott Laboratories (US) 2010-09-08 EP claimed
EP-2226074-A2 Pharmaceutical compositions and their methods of use Abbott Laboratories (US) 2010-09-08 EP disclosed